GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » PensionAndRetirementBenefit

ME Therapeutics Holding (XCNQ:METX) PensionAndRetirementBenefit : C$0.00 Mil (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding PensionAndRetirementBenefit?

ME Therapeutics Holding's PensionAndRetirementBenefit for the quarter that ended in Feb. 2024 was C$0.00 Mil.


ME Therapeutics Holding PensionAndRetirementBenefit Historical Data

The historical data trend for ME Therapeutics Holding's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding PensionAndRetirementBenefit Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
PensionAndRetirementBenefit
- -

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
PensionAndRetirementBenefit Get a 7-Day Free Trial - - - - -

ME Therapeutics Holding PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines